A Year In Review
Download this critical review for an in-depth look at the rapidly evolving cytokine therapy landscape. With over 3,000 therapies in development and a shift toward late-stage clinical focus, developers must navigate growing competition, regulatory scrutiny, and shifting investment trends.
Stay ahead with unmatched clinical and commercial insights from The Cytokine Landscape Review.
Download Now
Download the 2024 Cytokine Review for unparalleled information on the evolving cytokine landscape, from the rise of advanced modalities like bispecific antibodies and CAR-T cells to shifting clinical and regulatory trends. Gain insights into late-stage trial activity, recent approvals, and the changing investment climate shaping the future of cytokine therapies.
Report Contents
The Drug Landscape
A deep dive into the top therapeutic classes, disease indications and targets, as well as recent approvals and discontinuations.
The Trial Landscape
A breakdown of 2024’s cytokine clinical trials by phase progression, modality and target. Plus a list of early trial terminations.
The Commercial Landscape
Analysis of cytokine deal activity in 2024, including investment trends, and the evolving market dynamics shaping development.
The Future of the Cytokine Space
Upcoming trends, trials set to conclude in 2025, and strategic insights into the next wave of cytokine therapies set to shape the market.
Regulatory Announcements
A review of 2024 regulatory activity, including drug approvals, IND submissions, breakthrough designations, and compliance trends affecting cytokine therapies.
Previous Cytokine Landscape Reviews
Cytokine 2024 H1 Landscape Review
An analysis of the Cytokine landscape in H1 of 2024
You May Also Be Interested In…
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
